About Me

You'll have a better experience on this website using a secure, up-to-date browser. Click here for information and instructions about updating.

Dr. Joseph Keryakos

Dr. Joseph Keryakos
Assistant Professor of Health Sciences

Phone: (712) 722-6509
Email: Joseph.Keryakos@dordt.edu


Joseph Keryakos, PharmD, is the Assistant Professor of Health Sciences and the Pre-Health Professions Advisor in the Biology and Health & Human Performance (HHP) Departments. Dr. Keryakos joined Dordt University in June 2021, where he teaches and mentors students in pre-medicine, pre-pharmacy, pre-dentistry, pre-physical therapy, and other pre-professional programs.


Dr. Keryakos earned his Bachelor of Science in Biology in Honoribus with a minor in chemistry from Northern State University (NSU) in Aberdeen, SD. He then obtained his Bachelor of Science in Pharmaceutical Sciences with Honors College Distinction, followed by his Doctor of Pharmacy (PharmD) degree from South Dakota State University (SDSU) in Brookings, SD.

Work Experience

Prior to joining Dordt University, Dr. Keryakos worked as a Hospital Pharmacist Intern at Avera McKennan Hospital & University Health Center and Avera Behavioral Health Center. He also served in a variety of other roles within SDSU and NSU, including working as a Supplemental Instruction Leader and Teaching Assistant, Finance Vice President for the American Pharmacists Association Academy of Student Pharmacists, and Student Senator for the College of Pharmacy & Allied Health Professions. Prior to that, he served as a Senior Resident Assistant for Housing & Residence Life, and as an International Ambassador & Counselor for the Office of International Affairs.

Research Interests

His research interests lie in the areas of pharmacology, public health and wellness, human genetics, and cellular physiology. Recent research experiences were conducted in consultation with clinical pharmacists, pharmaceutical scientists, biologists, and geneticists. Among his latest publications as the lead author are “The Role of Sodium-Glucose Cotransporter-2 Inhibitors in Readmissions for Congestive Heart Failure,Journal of Young Pharmacists (2021) and “The Association of TAS1R2 to Dental and Cardiovascular Health,American Journal of Undergraduate Research (2019). Future prospective research projects include behavioral and molecular pharmacology, epigenetics and non-coding RNA, drug metabolism and metabolomics, and mechanistic toxicology.

Professional Affiliations

Dr. Keryakos holds memberships in regional, national, and international professional organizations, including the American Pharmacists Association (APhA), American Society of Health-System Pharmacists (ASHP), American College of Clinical Pharmacy (ACCP), National Community Oncology Dispensing Association (NCODA), Kappa Psi Pharmaceutical Fraternity, Fédération Internationale Pharmaceutique (FIP), South Dakota Society of Health-System Pharmacists (SDSHP), South Dakota Pharmacists Association (SDPhA), and South Dakota Academy of Science (SDAOS).